Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wilson TJ et al. – The authors have identified cathepsin G and MMP9 as proteases involved in enhanced TGF–beta signaling at the tumor–bone interface of mammary tumor–induced osteolytic lesions and have identified these proteases as potential therapeutic targets.

Related Articles

Radiologic observation: repair of focal bone erosions after humanized antitumor necrosis factor antibody adalimumab therapy in a patient with rheumatoid arthritis
Clinical Rheumatology, 10/22/09    Relevance Score: 67%

Developments in the scientific understanding of rheumatoid arthritis
Arthritis Research & Therapy, 10/28/09    Relevance Score: 66%

Osteologix to Continue Development of Osteoporosis Drug
Internet Source, 10/21/09    Relevance Score: 66%

COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation
Bone, 10/20/09    Relevance Score: 66%

Pathogenic bone loss in rheumatoid arthritis: mechanisms and therapeutic approaches
International Journal of Clinical Rheumatology, 10/19/09    Relevance Score: 65%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address